5 nominees · 3 ballot items.
Election of five directors; advisory approval of named executive officer compensation (Say-on-Pay); ratification of RSM US LLP as independent registered public accounting firm; and transacting other business as may properly come before the meeting.
Elect five director nominees (David P. Bovenzi, Andrew W. Dorn, Jr., Steven C. Finch, Robert M. Glaser, Susan R. Holliday) to serve until 2029.
Non-binding advisory vote to approve, on an annual basis, the compensation of the company's named executive officers as disclosed in the proxy statement.
The management proposal requests shareholder ratification, on a non-binding advisory basis, of the Company’s 2025 named executive officer compensation as disclosed in the proxy statement, including the Compensation Discussion and Analysis and related tables. Management frames the program as pay-for-performance with a mix of base salary, annual cash incentives (EIP) tied to PPNI, loan growth, deposit growth excluding BaaS, and net charge-off ratio, and long-term incentives (RSUs and PSUs) tied to ROAA and Relative ROAE; gateway capital requirements and individual performance scorecards apply. Management is seeking endorsement to validate its compensation design and to retain market-competitive pay practices; the Board recommends FOR, citing alignment with shareholder interests, use of independent consultants, clawback policies, stock ownership guidelines, and recent shareholder outreach. The vote is advisory and non-binding but will be considered by the MD&C Committee in future compensation decisions; the proxy discloses recent adjustments (e.g., supplemental RSUs after 2024 investment securities restructuring) and notes responses to shareholder feedback, including metric changes proposed for 2026 (TCBV replacing Relative ROAE). The Board’s justification rests on improved 2025 financial performance, rigorous governance, and compensation features intended to mitigate excessive risk-taking.
Ratify the selection of RSM US LLP as the Company's independent registered public accounting firm for 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PL Capital Advisors, LLC | 9.23% | 1,816,102 | $58M |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.82% | 948,441 | $30M |
| 3 | DIMENSIONAL FUND ADVISORS LP | 4.66% | 917,512 | $29M |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 4.25% | 837,514 | $27M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.24% | 835,538 | $26M |
| 6 | BlackRock, Inc. | 3.74% | 736,647 | $23M |
| 7 | BlackRock, Inc. | 3.06% | 602,976 | $19M |
| 8 | STATE STREET CORP | 2.94% | 579,119 | $19M |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 2.82% | 554,604 | $18M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.54% | 499,656 | $16M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.